14506 results for "PLOS+ONE+Pennsylvania+German+ACS+language+code+pdc+open+access+study"

in 30.17 milliseconds.

• Dyslipidemia

  These samples include exome sequences of family members with dyslipidemias from Finnish origin.

  Study EGAS00001000189

• Osteosarcoma_X10

  This is a continuation of the osteosarcoma work we have undertaken.

  Study EGAS00001002167

• Brain_Disease_Wellcome_Leap_Delta_Tissue_DNA

  Investigating how the tumour microenvironment regulates glioblastoma cell states using genomic analysis.

  Study EGAS00001005799

• Somatic_mutation_in_edited_cholangiocyte_organoids_NanoSeq

  Characterisation of mutation rates and patterns in edited human cholangiocyte organoids (NanoSeq)

  Study EGAS00001006405

• Somatic_mutation_in_edited_cholangiocyte_organoids__Targeted_NanoSeq_

  Characterisation of mutation rates and patterns in edited human cholangiocyte organoids (Targeted NanoSeq)

  Study EGAS00001007266

• Genomic characterization of metastatic breast cancers

  This dataset contains all the .bam files used for the study.

  Dataset EGAD00001004772

• Whole Exome Sequencing of INTERVAL

  Whole exome sequencing of a subset of participants from the INTERVAL study.

  Dataset EGAD00001002221

• Myeloma Targeted Follow-up Study

  Targeted sequencing follow-up of genomic lesions in multiple myeloma.

  Dataset EGAD00001001215

• NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (Ischemic Stroke Genetic Study, ISGS)

  The NHLBI "Grand Opportunity" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the human genome (the "exome") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public health and individuals from diverse racial and ethnic groups will be studied. These data may help researchers understand the causes of disease, contributing to better ways to prevent, diagnose, and treat diseases, as well as determine whether to tailor prevention and treatments to specific populations. This could lead to more effective treatments and reduce the likelihood of side effects. GO-ESP is comprised of five collaborative components: 3 cohort consortia - HeartGO, LungGO, and WHISP - and 2 sequencing centers - BroadGO and SeattleGO. The Ischemic Stroke Genetics Study (ISGS) is a study of newly onset cases (~600) with ischemic stroke (a stroke due to sudden interruption of blood flow to a part of the brain) compared with sex- and age-matched non-stroke participants. The study was conducted to determine the genes and their variants that contribute to an individual's risk of developing an ischemic stroke. The coordination of the recruitment and flow of the samples occurred at the Mayo Clinic, Jacksonville, FL, under the direction of James F. Meschia, MD. The University of Virginia (Stephen S. Rich, PhD) served as the analytic site for the genetic data. All GWAS data on ISGS participants have been deposited into dbGaP. As part of the NHLBI Exome Sequencing Project, DNA from a subset of ISGS participants will undergo exome sequencing. For the NHLBI ESP, a subset of 92 individuals with lacunar (small vessel) or atherosclerotic (large vessel) TOAST subtypes were selected from among all ISGS participants, excluding those individuals with TOAST subtypes of stroke of other etiology or of stroke with undetermined etiology. All 92 samples pass initial quality control metrics and 89 samples completed exome sequencing. A total of 75 participants with appropriate consent and variant calls had their genetic and phenotypic data deposited into dbGaP.

  Study phs000546

• CPCG-200PG-ARRAY

  Raw Array data from the CPCGene 200PG study

  Dataset EGAD00010001218

• Proteom study primary CRC and LM

  Proteom characterization in primary colorectal cancer and corresponding liver metastasis

  Dataset EGAD00010002237

• Single-Cell RNA-seq of Primary High Grade Serous Carcinoma

  Single-cell RNA Sequencing of CD45- cancer cells.

  Study EGAS50000000068

• Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort

  Study EGAS00001000096

• TRACERx NSCLC - Whole exome multiregion sequencing data

  Study EGAS00001006494

• Passive and active DNA methylation and the interplay with genetic variation in gene regulation

  Study EGAS00001000446

• Dnase1l3 knockout causes aberrations in plasma DNA fragmentation

  Dnase1l3 knockout causes aberrations in plasma DNA fragmentation

  Study EGAS00001003174

• ORCADES_15x

  15x whole genome sequencing in samples from the isolated population of Orkney

  Study EGAS00001001891

• HCA_Skin_Disease_WSSS_Spatial_NCL

  Defining the spatial transcriptome and cell-cell interactions in eczema and psoriasis skin

  Study EGAS00001005278

• Gene_Discovery_in_Age_Related_Hearing_Loss

  The aim is to find new candidate genes associated with progressive hearing loss

  Study EGAS00001000295

• Identifying_new_diagnostic_and_treatment_pathways_for_patients_with_unclassifiable_sarcomas

  Whole genome sequencing of tumour normal pairs of human undifferentiated sarcomas.

  Study EGAS00001001604

• Whole genome and transcriptome analysis of anaplastic thyroid carcinoma

  Whole genome and transcriptome analysis of anaplastic thyroid carcinoma

  Study EGAS00001001214

• SSBP1

  SSBP1 mutations cause a complex optic atrophy spectrum disorder with mitochondrial DNA depletion

  Study EGAS00001004003

• GIST_SSGXVIII_trial_targeted_gene_sequencing

  Targeted cancer gene sequencing of samples enrolled in the SSGXVIII trial from Finland.

  Study EGAS00001001054

• The_genetic_evolution_of_precursor_lesions_in_pancreatic_cancer

  Mapping genetic evolution of pancreatic cancer precursor lesions such as IPMNs and PanINs.

  Study EGAS00001001573

• BLUEPRINT EpiVar ChIP-seq of Monocytes & Neutrophils

  BLUEPRINT EpiVar ChIP-seq of Monocytes & Neutrophils

  Study EGAS00001000870